Cooper Companies vs STAAR Surgical
COO and STAA side by side, both in measuring, analyzing, and controlling instruments; photographic, medical and optical goods; watches and clocks. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How COO and STAA compare
Cooper Companies is the larger company, worth 9.2 times as much as STAAR Surgical ($11.3B against $1.2B).
On earnings, Cooper Companies is cheaper: it trades at 20.3× trailing earnings, against 351× for STAAR Surgical.
STAAR Surgical grew revenue faster over the last twelve months (51.3% versus 4.7% for Cooper Companies).
Cooper Companies keeps more of each dollar of sales as profit, with a net margin of 13.5% compared with 1.1% at STAAR Surgical.
Cooper Companies scores higher on the StockData Score (15 against 10 for STAAR Surgical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | COO | STAA |
|---|---|---|
| Size and price | ||
| Market cap | $11.3B | $1.2B |
| Share price | $59.55 | $24.54 |
| Change, 1 year | −14.4% | −7.7% |
| Change, 5 years | −43.8% | −78.8% |
| Beta (5Y) | 0.96 | 1.50 |
| Employees | 500 | 957 |
| StockData Score | ||
| Total score | 15 (better) | 10 |
| Valuation score | 6 (better) | 0 |
| Growth score | 1 | 2 (better) |
| Performance score | 3 (better) | 2 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 20.3× (better) | 351× |
| P/S | 2.7× (better) | 3.6× |
| P/B | 1.4× (better) | 3.4× |
| EV/EBITDA | 14.8× (better) | 76.4× |
| P/FCF | 16.7× | – |
| FCF yield | 6.0% (better) | −0.55% |
| Fair value | $101.80 | $15.38 |
| Margin of safety | 41.5% (better) | −59.6% |
| Growth | ||
| Revenue growth (TTM) | 4.7% | 51.3% (better) |
| Revenue growth, 5Y average | 11.0% (better) | 7.9% |
| Net income growth (TTM) | 39.8% | – |
| EPS growth (TTM) | 43.6% | – |
| EPS growth, 5Y average | 9.2% | – |
| Profitability | ||
| Gross margin | 65.9% | 76.6% (better) |
| Operating margin | 12.8% (better) | 4.0% |
| Net margin | 13.5% (better) | 1.1% |
| FCF margin | 16.0% (better) | −2.0% |
| Return on equity | 6.8% (better) | 1.1% |
| Return on invested capital | 5.1% (better) | 4.2% |
| Financial health | ||
| Debt / equity | 0.31 (better) | 0.00 |
| Net debt / EBITDA | 2.57 | – |
| Interest coverage | 6.1× | – |
| Current ratio | 1.22 | 4.66 (better) |
| Altman Z-score | 2.98 | 7.82 (better) |
| Piotroski F-score | 5 (better) | 2 |
| Dividends and buybacks | ||
| Buyback yield | 5.7% | – |
| Shareholder yield | 5.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 110% | 110% |
| Held by insiders | 0.65% | – |
| Insider net buying, 12 months | $3.2M | $62.8M (better) |
| Superinvestors holding | 2 | – |
| Short interest, % of float | 4.4% | – |
Go deeper
- COO stock overview
- COO income statement
- COO valuation and score
- STAA stock overview
- STAA income statement
- STAA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.